GlassScriptPhysician profile
Susan S Malley
NPI 1215959135
$2,305.83
in general payments reported to CMS, 2019-2025
31 companies · $21.62 in 2025
The $21.62 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,004 · 2020: $444 · 2021: $592 · 2022: $188 · 2024: $54.88 · 2025: $21.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $76.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $76.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $405.52 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $282.31 | 2019-2022 | |
| Therapeuticsmd, INC. | $203.26 | 2019-2021 | |
| Allergan, INC. | $191.65 | 2019-2020 | |
| Amarin Pharma, INC. | $130.43 | 2019-2020 | |
| Corcept Therapeutics | $120.70 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $89.69 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.65 | 2019-2022 | |
| Lupin INC. | $82.00 | 2019-2020 | |
| Pfizer INC. | $74.04 | 2020-2021 | |
| Avion Pharmaceuticals | $56.80 | 2019-2022 | |
| Astellas Pharma US INC | $54.88 | 2024 | Veozah |
| Novo Nordisk INC | $50.34 | 2019-2020 | |
| Hologic Sales and Service, LLC | $49.37 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $41.56 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $40.78 | 2019-2025 | Slynd |
| Recordati_rare_diseases_inc. | $38.31 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $37.43 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.15 | 2021 | |
| Pharming Healthcare, INC. | $26.09 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $24.71 | 2020 | |
| Organon LLC | $24.46 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $23.03 | 2020 | |
| Genentech USA, INC. | $21.22 | 2019 | |
| Abbott Laboratories | $20.39 | 2021 | |
| Bausch Health US, LLC | $19.03 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.18 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $15.81 | 2021 | |
| Janssen Biotech, INC. | $15.17 | 2021 | |
| Nestle Healthcare Nutrition INC. | $13.23 | 2021 | |
| Glaxosmithkline, LLC. | $12.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Malley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.